PharmiWeb.jobs: Global Life Science Jobs’ Post

ARLINGTON, Virginia—Knowland released the top market performance numbers for December, citing San Diego as having the highest meeting volume improvement with 29.2 percent year-over-year (YOY) growth. Coming in second was San Francisco, where event volume increased 21.5 percent. San Diego’s healthcare event business segment doubled, and its pharmaceutical/biotechnology events tripled from last year. Much of this meeting activity was held in the first half of the month. The top market experienced an average number of attendees of 198, and the average meeting space used was 2,577 square feet. https://lnkd.in/guaG6r8y

The Make-Or-Break Venue Factors For Pharma Events: From compliance with industry regulations to ensuring optimal attendee experience, selecting a venue for pharma events comes with its challenges. In the blog below, we break down the key factors to take into consideration when planning your next event. 👇 Check it out and share your thoughts! #TrinityEventSolutions #PharmaEvents #EventPlanning #VenueSelection #PharmaIndustry

🌟CALLING ALL PHARMACEUTICAL PROFESSIONALS! Join us at the WOCIP Cluster Meetings, where collaboration sparks innovation! See the exciting topics covered in all four targeted business meetings below! Stay tuned as we unveil the unique topics for each day! Join forces with peers in your role across the industry to tackle barriers to health equity together! 🌎 REGISTER BY APRIL 12th AND GET 50% OFF. Use the link and code in the comments. #WOCIP #HealthEquity #PharmaIndustry

I am thrilled to announce the DIA Meeting 2024, which took place from June 16-19! This event gathered the world's leading minds in healthcare, pharmaceuticals, and regulatory affairs to shape the future of our industry. Expect an enlightening and transformative experience packed with insights, innovations, and strategic discussions. Key Insights and Agenda Highlights: Innovative Therapies and Technologies: Discover advancements in biopharmaceuticals, medical devices, and digital health. Regulatory Science and Policy: Engage with global regulators on new guidelines and compliance strategies. Clinical Trials and Real-World Evidence: Explore innovative trial designs and the role of real-world evidence in drug development. Patient-Centric Approaches: Learn strategies for integrating patient perspectives into healthcare delivery. Being part of DIA Meeting 2024 was an immense pleasure. The enriching discussions and valuable insights from experts have inspired me to apply these learnings and collaborate with this vibrant community to advance healthcare. Special thanks to David Fryrear, Leslie Sam and Tywnia B. for their exceptional contributions. Also, kudos to my fellow participants RAJASHEKHAR ITTEDI for the poster presentation and Vandana Mandavilli, Rama D, and Keerthi Pendri for the case competition—you’ve provided valuable insights and inspiration. #DIA2024 #HealthcareInnovation #Pharmaceuticals #RegulatoryAffairs #PatientCentric #ClinicalTrials

Attention Pharma Professionals! Don't miss the inaugural edition of our Pharma News newsletter, landing in your inbox soon! Get exclusive insights, expert analyses, and content tailored just for you. Subscribe today and join the well-informed Pharma community.! ➡️ https://lnkd.in/gUgDRC_d #PharmaIndustry #PharmaUK #PharmaNews

ESMO started today! But here's something you might not know: 13 global pharma companies are relying on SpotMe Life Sciences' Congress Field Force App to manage all the logistical complexities of this congress. 4,000 commercial & medical reps will be using the app to engage with HCPs & enrich CRM records in real time. #ESMO #Healthcare #Pharmaceuticals #Congress #LifeSciences #PharmaEvents

💊💶🤐 Confidential drug prices coming to Germany ?! 🇩🇪 If you want to learn more about the draft law introducing confidential drug prices in Germany and the feedback from key stakeholders on the draft, then 👉 sign up for phraktion's next webinar right now :) See you there!

FirstWord Pharma spoke with Rashme Cardoza, Global Medical Affairs Consultant, formerly at GSK, about the future of pharma’s advisory boards and how their evolution is driving greater collaboration and innovation within the pharmaceutical industry. A few takeaways: 👩💻 Leveraging technology has revolutionized pharma's approach to seeking expertise and insights, allowing for greater accessibility, diversity, real-world evidence, and patient involvement, whilst being flexible and cost-effective. ⚕ This highlights the growing role of Medical Affairs, with a more strategic contribution to overall business decisions. 📏 Engagement metrics, reach, accessibility and decision impact are key to measuring effectiveness of virtual advisory boards. Read the full report here: https://lnkd.in/esktTKcE It was a pleasure interviewing you, Rashme Cardoza!

With the new European Parliament in place and a new European Commission forming, it's crucial to focus on ensuring the EU is set up for competitiveness, growth, and healthcare innovation. Key areas for progress include industrial competitiveness, intellectual property, regulatory frameworks, and access to new medicines. Flagship initiatives such as Europe’s Beating Cancer Plan, EU HTA, the revision of the General Pharmaceutical Legislation, and the European Health Data Space are pivotal. Our goal is clear: to ensure all European citizens fully benefit from medical and healthcare innovations. Discover BMS’ perspectives on these critical issues: https://bit.ly/3Xwrhyx #bmsaustria #healthcareinnovation

Attention Pharma Professionals! Don't miss the inaugural edition of our Pharma News newsletter, landing in your inbox soon! Get exclusive insights, expert analyses, and content tailored just for you. Subscribe today and join the well-informed Pharma community.! ➡️ https://lnkd.in/gUgDRC_d #PharmaIndustry #PharmaUK #PharmaNews